Abstract

Abstract Growing evidence suggests that breast cancer cells often reactivate latent developmental programs in order to efficiently execute the multi‐step process of tumorigenesis. This review focuses on key transcriptional regulators of embryonic development that are deregulated in breast cancer and discusses the molecular mechanisms by which these proteins control carcinogenesis. Reminiscent of their function during development, embryonic transcription factors regulate changes in gene expression that promote tumor cell growth, cell survival and motility, as well as a morphogenetic process called epithelial‐mesenchymal transition (EMT), which is implicated in both breast metastasis and tumor recurrence. Because of their pivotal roles in breast tumor progression, these factors represent valuable new biomarkers for breast cancer detection as well as promising new targets for anti‐invasive drugs. IUBMB Life, 58: 123‐132, 2006

Keywords

CarcinogenesisBreast cancerEpithelial–mesenchymal transitionMetastasisEmbryonic stem cellBiologyTranscription factorCancer researchCancerGeneGenetics

Affiliated Institutions

Related Publications

Publication Info

Year
2006
Type
review
Volume
58
Issue
3
Pages
123-132
Citations
32
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

32
OpenAlex

Cite This

Karoline J. Briegel (2006). Embryonic transcription factors in human breast cancer. IUBMB Life , 58 (3) , 123-132. https://doi.org/10.1080/15216540600686870

Identifiers

DOI
10.1080/15216540600686870